Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors

Natural killer T (NKT) cells are a small population of lymphocytes that possess characteristics of both innate and adaptive immune cells. They are uniquely poised to respond rapidly to infection and inflammation and produce cytokines that critically shape the ensuing adaptive cellular response. Ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Karsten A. Pilones, Joseph Aryankalayil, Sandra Demaria
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/720803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563322312982528
author Karsten A. Pilones
Joseph Aryankalayil
Sandra Demaria
author_facet Karsten A. Pilones
Joseph Aryankalayil
Sandra Demaria
author_sort Karsten A. Pilones
collection DOAJ
description Natural killer T (NKT) cells are a small population of lymphocytes that possess characteristics of both innate and adaptive immune cells. They are uniquely poised to respond rapidly to infection and inflammation and produce cytokines that critically shape the ensuing adaptive cellular response. Therefore, they represent promising therapeutic targets. In cancer, NKT cells are attributed a role in immunosurveillance. NKT cells also act as potent activators of antitumor immunity when stimulated with a synthetic agonist in experimental models. However, in some settings, NKT cells seem to act as suppressors and regulators of antitumor immunity. Here we briefly review current data supporting these paradoxical roles of NKT cells and their regulation. Increased understanding of the signals that determine the function of NKT cells in cancer will be essential to improve current strategies for NKT-cell-based immunotherapeutic approaches.
format Article
id doaj-art-dbc12cc63b9144dbb8969bf6c7a887d5
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-dbc12cc63b9144dbb8969bf6c7a887d52025-02-03T01:20:33ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/720803720803Invariant NKT Cells as Novel Targets for Immunotherapy in Solid TumorsKarsten A. Pilones0Joseph Aryankalayil1Sandra Demaria2Department of Pathology, NYU School of Medicine, 550 First Avenue, MSB-521, New York, NY 10016, USADepartment of Pathology, NYU School of Medicine, 550 First Avenue, MSB-521, New York, NY 10016, USADepartment of Pathology, NYU School of Medicine, 550 First Avenue, MSB-521, New York, NY 10016, USANatural killer T (NKT) cells are a small population of lymphocytes that possess characteristics of both innate and adaptive immune cells. They are uniquely poised to respond rapidly to infection and inflammation and produce cytokines that critically shape the ensuing adaptive cellular response. Therefore, they represent promising therapeutic targets. In cancer, NKT cells are attributed a role in immunosurveillance. NKT cells also act as potent activators of antitumor immunity when stimulated with a synthetic agonist in experimental models. However, in some settings, NKT cells seem to act as suppressors and regulators of antitumor immunity. Here we briefly review current data supporting these paradoxical roles of NKT cells and their regulation. Increased understanding of the signals that determine the function of NKT cells in cancer will be essential to improve current strategies for NKT-cell-based immunotherapeutic approaches.http://dx.doi.org/10.1155/2012/720803
spellingShingle Karsten A. Pilones
Joseph Aryankalayil
Sandra Demaria
Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
Clinical and Developmental Immunology
title Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
title_full Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
title_fullStr Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
title_full_unstemmed Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
title_short Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
title_sort invariant nkt cells as novel targets for immunotherapy in solid tumors
url http://dx.doi.org/10.1155/2012/720803
work_keys_str_mv AT karstenapilones invariantnktcellsasnoveltargetsforimmunotherapyinsolidtumors
AT josepharyankalayil invariantnktcellsasnoveltargetsforimmunotherapyinsolidtumors
AT sandrademaria invariantnktcellsasnoveltargetsforimmunotherapyinsolidtumors